EE16 A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk
Abstract
Authors
Marlene Panzer Llywelyn Cadman-Davies Nicholas A. Kennedy Stefan Lindgren Johannes Pöhlmann Richard F. Pollock